MedinCell announces filing of its document de base with the AMF, the first step towards its planned IPO on the regulated market of Euronext in Paris September 5, 2018 September 5, 2018
MedinCell receives grant to develop long-acting injectable contraceptive December 7, 2017 December 7, 2017
